Clinical Trial Update: A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a BCMA CAR-T cell therapy in newly diagnosed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA CAR-T Cell Therapy

Snippet

Sponsor: Zhejiang University | Conditions: Multiple Myeloma, New Diagnosis Tumor | Phase 2 | Status: UNKNOWN